Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 5, 2013, Pages 773-781

  Chen, Xiaohong ^a   Zhang, Boheng ^a   Yin, Xin ^a   Ren, Zhenggang ^a   Qiu, Shuangjian ^a   Zhou, Jian ^a  

^a Liver Cancer Institute   (China)

Author keywords

Curative resection; Hepatocellular carcinoma; Lipiodolized transarterial chemoembolization; Recurrence; Survival

Indexed keywords

CISPLATIN; FLUOROURACIL; IODINATED POPPYSEED OIL; MITOMYCIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR THROMBUS;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; ETHIODIZED OIL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RISK FACTORS;

EID: 84876291499     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1343-7     Document Type: Article

References (26)

1. Boucher E, Corbinais S, Rolland Y et al (2003) Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology 38:1237-1241. doi: 10.1053/jhep.2003.50473
2. Huo TL, Lui WY, Wu JC et al (2004) Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg 28:258-262. doi: 10.1007/s00268-003-7182-6
3. Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200-207. doi: 10.1016/S0168-8278(02)00360-4
4. Iwai K, Maeda H, Konno T (1984) Use of oily contrast-medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res 44:2115-2121
5. Izumi R, Shimizu K, Iyobe T et al (1994) Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular-carcinoma. Hepatology 20:295-301. doi: 10.1002/hep.1840200205
6. Ju MJ, Qiu SJ, Fan J et al (2009) Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. J Gastroenterol 44:635-642. doi: 10.1007/s00535-009-0050-x
7. Kanematsu T, Inokuchi K, Sugimachi K et al (1984) Selective effects of lipiodolized antitumor agents. J Surg Oncol 25:218-226. doi: 10.1002/jso.2930250317
8. Kwok PCH, Lam TW, Lam PWY et al (2003) Randomized controlled trial to compare the dose of adjuvant chemotherapy after curative resection of hepatocellular carcinoma. J Gastroenterol Hepatol 18:450-455. doi: 10.1046/j.1440-1746.2003.03015.x
9. Lai EC, Lo CM, Fan ST et al (1998) Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 133:183-188. doi: 10.1001/archsurg.133.2.183
10. Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7:237-257
11. Lee JK, Chung YH, Song BC et al (2002) Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17:52-58. doi: 10.1046/j.1440-1746. 2002.02664.x
12. Li JQ, Zhang YQ, Zhang WZ et al (1995) Randomized study of chemoembolization as an adjuvant therapy for primary liver-carcinoma after hepatectomy. J Cancer Res Clin Oncol 121:364-366. doi: 10.1007/BF01225689
13. Li MS, Ma QL, Chen Q et al (2005) Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells. World J Gastroenterol 11:2564-2569
14. Peng BG, He Q, Li JP, Zhou F (2009) Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 198:313-318. doi: 10.1016/j.amjsurg.2008.09.026
15. Qian YB, Zhang JB, Wu WZ et al (2006) P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer 107:1562-1569. doi: 10.1002/cncr.22206
16. Ren Z-G, Lin Z-Y, Xia J-L et al (2004) Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. World J Gastroenterol 10:2791-2794
17. Roayaie S, Frischer JS, Emre SH et al (2002) Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235:533-539. doi: 10.1097/00000658-200204000-00012
18. Sakon M, Nagano H, Nakamori S et al (2002) Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 137:94-99. doi: 10-1001/pubs.ArchSurg-ISSN-0004-0010- 137-1-soa1134
19. Samuel M, Chow PKH, Shih-Yen EC et al (2009) Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst Rev. doi: 10.1002/14651858.CD001199.pub2
20. Shah SA, Cleary SP, Wei AC et al (2007) Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 141(3):330-339. doi: 10.1016/j.surg.2006.06.028
21. Sun HC, Tang ZY (2003) Preventive treatments for recurrence after curative resection of hepatocellular carcinoma: a literature review of randomized control trials. World J Gastroenterol 9:635-640
22. Sun HC, Zhang W, Qin LX et al (2007) Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47:684-690. doi: 10.1016/j.jhep.2007.06.019
23. Takayama T, Sekine T, Makuuchi M et al (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356:802-807. doi: 10.1016/S0140-6736(00)02654-4
24. Tsai TJ, Chau GY, Lui WY et al (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603-608. doi: 10.1067/msy.2000.105498
25. Yamashita Y, Takahashi M, Koga Y et al (1991) Prognostic factors in the treatment of hepatocellular-carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 67:385-391. doi: 10.1002/1097-0142(19910115)67: 2<385:AID-CNCR2820670212>3.0.CO;2-Q
26. Zhong C, Guo RP, Li JQ et al (2009) A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol 135:1437-1445. doi: 10.1007/s00432-009-0588-2